Study: Many cancer drugs unproven 5 years after accelerated approval
The U.S. Food and Drug Administration’s accelerated approval program is meant to give patients early access to promising drugs. But how often do these drugs actually improve or extend patients’ lives?
In a new study, researchers found that most cancer drugs granted accelerated approval do not demonstrate such benefits within five years.
“Five years after the initial accelerated approval, you should have a definitive answer,” said Dr. Ezekiel Emanuel, a cancer specialist and bioethicist at the University of Pennsylvania who was not involved in the research. “Thousands of people are getting those drugs. That seems a mistake if we don’t know whether they work or not.”
The program was created in 1992 to speed access to HIV drugs. Today, 85% of accelerated approvals go to cancer drugs.
It allows the FDA to grant early approval to drugs that show promising initial results for treating debilitating or fatal diseases. In exchange, drug companies are expected to do rigorous testing and produce better evidence before gaining full approval.
Related articles
Saudi Arabia is going to sponsor the WTA women's tennis rankings under a new partnership
NEW YORK (AP) — Saudi Arabia’s move into tennis will now include a multiyear deal to sponsor the WTA2024-05-21Chinese yuan strengthens to 7.0947 against USD Monday
BEIJING, April 8 (Xinhua) -- The central parity rate of the Chinese currency renminbi, or the yuan,2024-05-21Xi Meets German Chancellor Olaf Scholz
Contact Us HomeNewsHighlightACWF NewsSocietyWom2024-05-21Federation Cultivates 'Legal Docents' to Help Protect Women's Rights
Contact Us HomeNewsHighlightACWF NewsSocietyWom2024-05-21Investigators return to Long Island home of Gilgo Beach serial killing suspect
MASSAPEQUA PARK, N.Y. (AP) — Investigators returned Monday to the home of a New York architect charg2024-05-21(CPC Congress) New CPC Leadership to Meet Press on Sunday
Contact Us HomeNewsHighlightACWF NewsSocietyWom2024-05-21
atest comment